Elimination of lipid peroxide during hemodialysis

Nephron - Clinical Practice

Volumn 106, Issue 4, 2007, Pages

  Obara, Mami ^a,b   Hirayama, Aki ^b   Gotoh, Michihiro ^c   Ueda, Atsushi ^d   Ishizu, Takashi ^e   Taru, Yoshinori ^e   Shimozawa, Yukari ^b   Yamagata, Kunihiro ^b   Nagase, Sohji ^f   Koyama, Akio ^g  

^a Tsukuba Gakuen Hospital   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c Hitachi   (Japan)

^d Namegata District General Hospital   (Japan)

^e Tsukuba Central Hospital   (Japan)

^f INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^g IBARAKI PREFECTURAL UNIVERSITY OF HEALTH SCIENCES   (Japan)

Author keywords

Apolipoprotein A I; Cholesteryl ester hydroperoxide; Free radical; Hemodialysis; Hydroxyl radical; Lecithin:cholesterol acyltransferase; Oxidative stress; Phosphatidylcholine hydroperoxide

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL ESTER; LIPID PEROXIDE; MALONALDEHYDE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; LIPID PEROXIDATION; MAINTENANCE THERAPY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LIPID PEROXIDES; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 34547437345     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000104427     Document Type: Article

References (31)

1. Nagase S, Aoyagi K, Hirayama A, Gotoh M, Ueda A, Tomida C, Kamezaki T, Nagai Y, Kikuchi H, Koyama A: Favorable effect of hemodialysis on decreased serum antioxidant activity in hemodialysis patients demonstrated by electron spin resonance. J Am Soc Nephrol 1997;8:1157-1163.
2. Hirayama A, Nagase S, Gotoh M, Takemura K, Tomida C, Ueda A, Aoyagi K, Terao J, Koyama A: Hemodialysis does not influence the peroxidative state already present in uremia. Nephron 2000;86:436-440.
3. Woods HF, Nandakumar M: Improved outcome for haemodialysis patients treated with high-flux membranes. Nephrol Dial Transplant 2000;15(suppl 1):36-42.
4. Locatelli F, Manzoni C, Di Filippo S: The importance of convective transport. Kidney Int 2002;61(suppl 80):115-120.
5. Shimazu T, Ominato M, Toyama K, Yasuda T, Sato T, Maeba T, Owada S, Ishida M: Effects of a vitamin E-modified dialysis membrane on neutrophil superoxide anion radical production. Kidney Int Suppl 2001;78:S137-143.
6. Sanaka T, Takahashi C, Sanaka M, Higuchi C, Shinobe M, Hayasaka Y, Miyazawa T, Ishikawa S, Nihei H, Omori Y: Accumulation of phosphatydilcholine- hydroperoxide in dialysis patients with diabetic nephropathy. Clin Nephrol 1995;44(suppl 1):S33-37.
7. Bayes B, Pastor MC, Bonal J, Junca J, Romero R: Homocysteine and lipid peroxidation in haemodialysis: role of folinic acid and vitamin E. Nephrol Dial Transplant 2001;16:2172-2175.
8. Srinivasa Rao PV, Dakshinamurty KV, Saibaba KS, Sheela RB, Venkataramana G, Sreekrishna V, Ambekar JG, Jayaseelan L: Oxidative stress in haemodialysis: immediate changes caused by passage of blood through the dialyser. Ann Clin Biochem 2001;38:401-405.
9. Srinivasa Rao PV, Dakshinamurty KV, Saibaba KS, Raghavan MS, Vijayabhaskar M, Sreekrishna V, Ambekar JG, Jayaseelan L: Oxidative stress in haemodialysis: intradialytic changes. Redox Rep 2001;6:303-309.
10. Roob JM, Khoschsorur G, Tiran A, Horina JH, Holzer H, Winklhofer-Roob BM: Vitamin E attenuates oxidative stress induced by intravenous iron in patients on hemodialysis. J Am Soc Nephrol 2000;11:539-549.
11. Sattler W, Christison J, Stocker R: Cholesterylester hydroperoxide reducing activity associated with isolated high- and low-density lipoproteins. Free Radic Biol Med 1995;18:421-429.
12. Garner B, Witting PK, Waldeck AR, Christison JK, Raftery M, Stocker R: Oxidation of high density lipoproteins. I. Formation of methionine sulfoxide in apolipoproteins AI and AII is an early event that accompanies lipid peroxidation and can be enhanced by alpha-tocopherol. J Biol Chem 1998;273:6080-6087.
13. Garner B, Waldeck AR, Witting PK, Rye KA, Stocker R: Oxidation of high density lipoproteins. II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII. J Biol Chem 1998;273:6088-6095.
14. Mashima R, Yoshimura S, Yamamoto Y: Reduction of lipid hydroperoxides by apolipoprotein B-100. Biochem Biophys Res Commun 1999;259:185-189.
15. Yamamoto Y: Fate of lipid hydroperoxides in blood plasma. Free Radic Res 2001;33:795-800.
16. Dudman NP, Wilcken DE, Stocker R: Circulating lipid hydroperoxide levels in human hyperhomocysteinemia: relevance to development of arteriosclerosis. Arterioscler Thromb 1993;13:512-516.
17. Noguchi N, Gotoh N, Niki E: Dynamics of the oxidation of low density lipoprotein induced by free radicals. Biochim Biophys Acta 1993;1168:348-357.
18. Chancharme L, Therond P, Nigon F, Lepage S, Couturier M, Chapman MJ: Cholesteryl ester hydroperoxide lability is a key feature of the oxidative susceptibility of small, dense LDL. Arterioscler Thromb Vasc Biol 1999;19:810-820.
19. Polidori MC, Frei B, Cherubini A, Nelles G, Rordorf G, Keaney JJ, Schwamm L, Mecocci P, Koroshetz WJ, Beal MF: Increased plasma levels of lipid hydroperoxides in patients with ischemic stroke. Free Radic Biol Med 1998;25:561-567.
20. Kamezaki T, Yanaka K, Nagase S, Fujita K, Kato N, Nose T: Increased levels of lipid peroxides as predictive of symptomatic vasospasm and poor outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg 2002;97:1302-1305.
21. Nagata Y, Yamamoto Y, Niki E: Reaction of phosphatidylcholine hydroperoxide in human plasma: the role of peroxidase and lecithin: cholesterol acyltransferase. Arch Biochem Biophys 1996;329:24-30.
22. Baoutina A, Dean RT, Jessup W: Macrophages can decrease the level of cholesteryl ester hydroperoxides in low density lipoprotein. J Biol Chem 2000;275:1635-1644.
23. Terao J, Asano I, Matsushita S: High-performance liquid chromatographic determination of peroxidation products of rat liver after carbon tetrachloride administration. Arch Biochem Biophys 1984;235:326-333.
24. Hirayama A, Nagase S, Gotoh M, Ueda A, Ishizu T, Yoh K, Aoyagi K, Terao J, Koyama A: Reduced serum hydroxyl radical scavenging activity in erythropoietin therapy resistant renal anemia. Free Radic Res 2002;36:1155-1161.
25. Polidori MC, Frei B, Rordorf G, Ogilvy CS, Koroshetz WJ, Beal MF: Increased levels of plasma cholesteryl ester hydroperoxides in patients with subarachnoid hemorrhage. Free Radic Biol Med 1997;23:762-767.
26. Kaysen GA: Hyperlipidemia of chronic renal failure. Blood Purif 1994;12:60-67.
27. Morena M, Delbosc S, Dupuy AM, Canaud B, Cristol JP: Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation. Hemodial Int 2005;9:37-46.
28. Dursun E, Ozben T, Suleymanlar G, Dursun B, Yakupoglu G: Effect of hemodialysis on the oxidative stress and antioxidants. Clin Chem Lab Med 2002;40:1009-1013.
29. Halliwell B, Gutteridge JMC: Mechanisms of damage to cellular targets by oxidative stress: lipid peroxidation; in Halliwell B, Gutteridge JHC (eds): Free Radicals in Biology and Medicine. London. Oxford Science Publications, 1999, pp 284-313.
30. Yamamoto Y, Nagata Y, Niki E, Watanabe K, Yoshimura S: Plasma glutathione peroxidase reduces phosphatidylcholine hydroperoxide. Biochem Biophys Res Commun 1993;193:133-138.
31. Belcher JD, Marker PH, Geiger P, Girotti AW, Steinberg MH, Hebbel RP, Vercellotti GM: Low-density lipoprotein susceptibility to oxidation and cytotoxicity to endothelium in sickle cell anemia. J Lab Clin Med 1999;133:605-612.